Skip to main content
. 2024 Feb 23;20(4):900–930. doi: 10.1007/s12015-023-10675-2

Fig. 3.

Fig. 3

Stem cell EVs as therapeutics for COVID-19. A EVs derived from stem cells of various origins were investigated in the form of whole EVs or specific EV-associated cargos. B EVs are administered via different routes, in both clinical and preclinical studies